22 May, 2025Review of pharmaceutical legislation, the key opportunity to relaunch U.S. competitivenessNathalie Moll (EFPIA) warns in an interview with Health35 that the lack of regulatory consistency and proposed environmental changes threaten investment in biomedical R&D in Europe. […]